Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Headwaters Capital 2024 Q2 Investor Letter | Buyside Digest

Back to Fund Profile (Headwaters Capital)

Primary Source Intelligence • Q2 2024 Letter Analysis

Headwaters Capital Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Headwaters Capital. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Digest Analysis

Quick Take

"Headwaters outperformed by 450bp in Q2 with growing conviction in small caps trading at historic discounts to large caps. TransMedics delivered strong results while Inspire faced temporary headwinds."

Executive Summary

Headwaters Capital returned +1.1% net in Q2 2024, outperforming the Russell Mid Cap Index by 450 basis points. The manager's conviction in small cap opportunities has grown given their continued underperformance relative to large caps, creating historically wide valuation discounts for high ROE businesses. The portfolio benefited from TransMedics' strong results and raised guidance, validating their organ care system strategy. Inspire Medical faced multiple headwinds including plateauing utilization and competitive concerns from weight loss drugs, though the manager views these as temporary issues. The quarter's major addition was PDF Solutions, a semiconductor yield optimization company that has completed a business model transition and is positioned to benefit from increasing manufacturing complexity and new foundry investments. The AI theme continues to drive concentrated returns in large caps, obscuring broader market weakness. The manager remains optimistic about portfolio company earnings growth potential and the opportunity set in competitively advantaged small and mid-cap businesses trading at attractive valuations.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

72%

CautiousHigh

High Conviction (72%)

The manager demonstrates high conviction through detailed analysis of individual positions, willingness to hold through volatility (Inspire Medical), and growing conviction in small caps. The extensive PDF Solutions thesis and specific position sizing discussions indicate strong conviction, though the smaller initial position size for PDF Solutions reflects some caution around complexity.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The manager expresses optimism about small cap opportunities and growing conviction in the opportunity set, but acknowledges market concentration in AI and large caps. The outlook is constructive but measured, with recognition of current market dynamics favoring large caps over the manager's focus area.

Risk Appetite

40%

DefensiveAggressive

Defensive (40%)

The portfolio added one new position (PDF Solutions) but started it at a smaller size than typical due to complexity. The manager continues to hold Inspire Medical through headwinds and expresses willingness to add to PDF Solutions as confidence grows. This suggests moderate risk appetite with selective positioning.

Capital Deployment

25%

De-riskingDeploying

De-risking (25%)

The manager added one new position (PDF Solutions) but at a smaller size than typical initial positions. No sales were made during the quarter. This represents modest net deployment with a cautious approach to the new position sizing.

Forward Guidance

30%

CautiousExpansionary

Cautious (30%)

The manager plans to potentially add to the PDF Solutions position as confidence grows and will patiently hold Inspire Medical through near-term challenges. The guidance suggests selective deployment with a monitoring approach rather than aggressive action.

Language Signal

35%

BearishBullish

Bearish (35%)

Language includes positive terms like 'growing conviction,' 'optimism,' and 'attractive valuations' but is balanced with acknowledgment of headwinds, temporary issues, and market concentration concerns. The tone is constructive but measured.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

The manager acknowledges market concentration risks from AI theme dominance and specific company-level challenges (Inspire Medical headwinds, PDF Solutions complexity). Risks are discussed but not characterized as systemic or alarming, representing moderate risk awareness.

Opportunity Density

65%

ScarceAbundant

Abundant (65%)

The manager sees growing opportunities in small caps trading at historic discounts and identifies specific investment themes like semiconductor complexity. The addition of PDF Solutions and expressed willingness to add more suggests a reasonably rich opportunity set in the manager's focus areas.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

The manager explicitly states willingness to 'patiently endure growing pains' with Inspire Medical and expects results 'next year.' The focus on businesses with 'long and durable runways for revenue growth' and multi-year thesis development for PDF Solutions indicates a patient, multi-year investment horizon.